Skip to main content
. 2021 Feb 25;12:633625. doi: 10.3389/fendo.2021.633625

Figure 1.

Figure 1

Effects of twice-daily administration of sea lamprey PYY [SL-PYY (1-36)] on (A, B) body weight, (C, D) % body weight change as well as cumulative (E, F) food and (G, H) fluid intake in streptozotocin (STZ)-diabetic GluCreERT2;Rosa26-eYFP and Ins1Cre/+;Rosa26-eYFP mice. Parameters were measured prior to, and 11 days during, twice daily treatment with saline vehicle or SL-PYY(1-36) (25 nmol/kg bw) in STZ-diabetic GluCreERT2;Rosa26-eYFP and Ins1Cre/+;Rosa26-eYFP mice. Values are mean ± SEM (n=6). Δp < 0.05, ΔΔp < 0.01, ΔΔΔp < 0.001 compared to appropriate non-diabetic control. *p < 0.05, **p < 0.01, ***p < 0.001 compared to appropriate STZ-diabetic control.